Randomized, Double-Blind, Placebo-Controlled, Phase I Dose-Escalation Study of Single Dose GHB04L1 in Healthy Adults.
Phase of Trial: Phase I
Latest Information Update: 25 Apr 2014
At a glance
- Drugs Influenza virus delta-NS1 vaccine (Primary)
- Indications Influenza A virus H5N1 subtype
- Focus Adverse reactions
- Sponsors AVIR Green Hills Biotechnology
- 03 Mar 2010 Actual number of patients (32) and actual end date (Mar 2010) added as reported by ClinicalTrials.gov.
- 03 Mar 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 17 Sep 2008 New trial record.